, Tracking Stock Market Picks
Enter Symbol:
Ligand Pharmaceuticals Incorporated (LGND) [hlAlert]

up 666.26 %

Ligand Pharmaceuticals Incorporated (LGND) rated Outperform with price target $5 by Oppenheimer

Posted on: Thursday,  Jan 22, 2009  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) on 01/22/2009, when the stock price was $12.30. Since
then, Ligand Pharmaceuticals Incorporated has gained 666.26% as of 09/30/2015's recent price of $94.25.
If you would have followed this Oppenheimer's recommendation on LGND, you would have gained 666.26% of your investment in 2442 days.

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/22/2009 8:25 AM Buy
12.30 30.00
as of 12/31/2009
1 Week up  295.89 %
1 Month up  337.87 %
3 Months up  275.32 %
1 YTD up  322.92 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy